; (B) the capacity of such existing laboratories to effectively meet national goals to counter threats to biosafety and biosecurity; (C) the aggregate risks associated with— (i) such existing laboratories; and (ii) expanding the numbers and facilities of such laboratories; and (D) the type of oversight needed for high-containment laboratories; and (2) up-to-date national standards, developed by the Federal official designated under subsection (a) in consultation with the scientific community, for the design, construction, commissioning, operation, and long-term maintenance of high-containment laboratories. (c) Reporting Upon completion of each strategic evaluation under subsection, (a), the Federal official designated under subsection (a) shall submit to the President and the Congress a report on the results of such evaluation and include in each such report recommendations on— (1) addressing gaps in Federal oversight of high-containment laboratories; and (2) utilizing high-containment laboratories for protecting public health and ensuring biosecurity in the United States. (d) Public Health and Biosecurity Team (1) In general The Federal official designated under subsection (a) shall maintain a team, to be known as the Public Health and Biosecurity Team, to serve as a single point of contact for State and local agencies regarding questions of public health relating to laboratory biosafety and biosecurity. (2) Establishment The Federal official designated under subsection (a) shall establish the Public Health and Biosecurity Team, as required by paragraph (1), not later than one year after such official is first designated. (3) Duties The Public Health and Biosecurity Team shall be the primary point of contact in the Federal Government for State and local agencies on— (A) issues related to— (i) oversight of high-containment laboratories; (ii) the impact of high-containment laboratories on public health